LEVERAGED LONG CERTIFICATE - PFIZER INC Stock

Certificat

SPFI5L

DE000SH10011

Market Closed - Borsa Italiana 16:04:59 2024-06-07 EDT
0.1665 EUR -3.48% Intraday chart for LEVERAGED LONG CERTIFICATE - PFIZER INC
Current month+2.34%
1 month+15.13%
Date Price Change
24-06-07 0.175 +1.45%
24-06-06 0.1725 -12.66%
24-06-05 0.1975 +3.13%
24-06-04 0.1915 +2.41%
24-06-03 0.187 +9.36%

Real-time Borsa Italiana

Last update June 07, 2024 at 04:04 pm

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
SPFI5L
ISINDE000SH10011
Date issued 2022-01-26
Maturity Unlimited
Parity 1 : 1
Emission price 20
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 22.06
Lowest since issue 0.1005
Spread 0.0025
Spread %1.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.58 USD
Average target price
31.92 USD
Spread / Average Target
+11.67%
Consensus
  1. Stock Market
  2. Certificates
  3. SPFI5L Certificat